These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30725050)

  • 1. [Delayed hemolytic reaction to transfusion in sickle cell anemia. Report of one case].
    Moya F; Rivera M; Araya F; Donoso J; Sandoval P; Varas P
    Rev Med Chil; 2018 Nov; 146(11):1347-1350. PubMed ID: 30725050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
    Blauel ER; Grossmann LT; Vissa M; Miller ST
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e438-40. PubMed ID: 26207780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia.
    Fabron A; Moreira G; Bordin JO
    Sao Paulo Med J; 1999 Jan; 117(1):38-9. PubMed ID: 10413970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
    Vlachaki E; Gavriilaki E; Kafantari K; Adamidou D; Tsitsikas D; Chasapopoulou E; Anagnostopoulos A; Tsapas A
    Hemoglobin; 2018; 42(5-6):339-341. PubMed ID: 30626228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
    Pirenne F; Yazdanbakhsh K
    Blood; 2018 Jun; 131(25):2773-2781. PubMed ID: 29724898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease.
    Reyes MA; Illoh OC
    Immunohematology; 2008; 24(2):45-51. PubMed ID: 19852130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A delayed hemolytic transfusion reaction due to anti-Cob.
    Squires JE; Larison PJ; Charles WT; Milner PF
    Transfusion; 1985; 25(2):137-9. PubMed ID: 3984006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed hemolytic transfusion reaction in children with sickle cell disease.
    de Montalembert M; Dumont MD; Heilbronner C; Brousse V; Charrara O; Pellegrino B; Piguet C; Soussan V; Noizat-Pirenne F
    Haematologica; 2011 Jun; 96(6):801-7. PubMed ID: 21330322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM; Miller MJ; Chonat S; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risks associated with transfusions in sickle cell disease: delayed hemolytic transfusion reaction].
    Habibi A; Noizat-Pirenne F
    Rev Prat; 2014 Oct; 64(8):1128-9. PubMed ID: 25510142
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed hemolytic transfusion reactions in sickle cell anemia.
    Rao KR; Patel AR
    South Med J; 1989 Aug; 82(8):1034-6. PubMed ID: 2762885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-N and anti-Do
    Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.
    Mekontso Dessap A; Pirenne F; Razazi K; Moutereau S; Abid S; Brun-Buisson C; Maitre B; Michel M; Galacteros F; Bartolucci P; Habibi A
    Am J Hematol; 2016 Dec; 91(12):1181-1184. PubMed ID: 27538126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K; Hoppe C; Mijovic A; Thein SL
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs.
    Madu AJ; Ugwu AO; Efobi C
    Med Princ Pract; 2021; 30(3):236-243. PubMed ID: 33176303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.
    Jasinski S; Glasser CL
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):624-626. PubMed ID: 30179992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe.
    Ferlis M; Lipato T; Roseff SD; Smith WR
    Eur J Haematol; 2022 Nov; 109(5):586-589. PubMed ID: 35848827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe delayed hemolytic transfusion reaction secondary to anti-At(a).
    Cash KL; Brown T; Sausais L; Uehlinger J; Reed LJ
    Transfusion; 1999 Aug; 39(8):834-7. PubMed ID: 10504118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.